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Advances in obstetric care, alongside efforts to 
implement best practices, have not diminished the 
need for critical care facilities. Obstetric patients 
constitute 1.8% of intensive care unit (ICU) 
admissions in a well-resourced country like the UK,[1] 
but this rises to 23.7% in under-resourced countries.[2] 
Globally, the ICU constitutes an expensive service and demand 
typically exceeds the supply of available beds; therefore, triage is 
essential, in order to favour those who have better chances of survival. 
There is a perception that HIV-positive patients tend to have poor 
outcomes, particularly if they are antiretroviral therapy (ART) naive; 
this may bias clinicians against admitting such patients to limited 
ICU resources. Although Bhagwanjee et al.[3] had previously shown 
that HIV infection in adults did not predict ICU mortality, their 
study was undertaken at a very early stage of the HIV epidemic in 
South Africa (SA), when there were few AIDS cases and ART was 
not available.
Predicting ICU survival among critically ill patients, particularly 
pregnant women, is very challenging. Available ICU scoring systems 
which predict ICU survival and mortality have shown inconsistent 
results in pregnant patients.[4] This may be because conventional 
scoring systems do not factor in the physiological changes of 
pregnancy. To address these issues, Paruk developed and validated 
the GRAMPT scoring system for pregnant and post partum patients 
in 2007 (see a detailed description of the GRAMPT system below). 
They found that, when used within the first 24 hours of ICU 
admission, their model was superior to the Acute Physiology and 
Chronic Health Evaluation (APACHE) II system in predicting 
mortality. Moreover, the mortality predicted by the GRAMPT model 
correlated with the magnitude of the inflammatory response, as well 
as the number and duration of organ failures.[5]
The HIV pandemic has become increasingly feminised, with 
young women comprising 58% of people living with HIV in Sub-
Saharan Africa.[6] In SA in 2010, HIV prevalence among antenatal 
clinic attendees was 30.2%, with the highest prevalence (42.3%) in the 
Pietermaritzburg area.[7] These high rates have made HIV/AIDS the 
most common cause of maternal deaths in SA. For socio-economic 
and administrative reasons, not all HIV-positive pregnant patients 
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Background. Outcomes of HIV-positive pregnant patients admitted to intensive care units (ICUs) are controversial.
Objective. To determine maternal and fetal outcomes of HIV-positive patients admitted to ICUs.
Methods. Pregnant patients admitted to ICUs were enrolled in the study. On admission, they were classified as having low (<50%) or high 
(≥50%) risk of death by GRAMPT stratification score. The primary maternal outcome was death or hypoxic-ischaemic brain injury (HIBI), 
while fetal outcomes recorded were Apgar score, birth weight, and delivery of the fetus to facilitate maternal care.
Results. There were 84 admissions to the ICUs: 66 (78.6%) were post-partum and 18 (21.4%) antepartum. The HIV sero-status was as 
follows: 11 (13.1%) HIV status unknown; 42 (50%) HIV-negative and 31 (36.9%) HIV-positive. The most common pre-ICU admission 
diagnoses were pneumonia (19.4%) in HIV-positive patients and eclampsia (31%) in HIV-negative patients. Maternal outcomes showed a 
worsening trend among the HIV-positive women when compared with those who were HIV-negative (high GRAMPT, 1.91 relative risk of 
death/HIBI in HIV-positive; 95% CI 0.57 - 6.44). Forty-two patients gave birth within 24 hours prior to ICU admission; 3 gave birth while 
in ICU and none gave birth within 24 hours following ICU discharge. Outcomes of the 45 infants born to HIV-positive women were worse 
than for those born to HIV-negative patients (except for Apgar scores 1 - 6). Performance of the GRAMPT model for prediction of maternal 
mortality/HIBI was best in hypertensive patients (ROC: AUC 0.72; 95% CI 0.48 - 0.96).
Conclusion. With the exception of Apgar scores 1 - 6, all outcomes showed worsening trends among infants born to HIV-positive mothers. 
Large multicentre studies are needed to confirm our findings.
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receive ART.[8] This can potentially lead to infectious complications 
which may increase the likelihood of HIV-positive pregnant women 
requiring ICU admission. 
Given the high incidence of HIV infection and the scarcity of 
ICU facilities in our environment, we performed a prospective study 
to determine the maternal and fetal outcomes of HIV-positive and 
-negative patients who were either pregnant or up to 42 days post 
partum, who were admitted to ICUs. As well as improving the scarcity 
of published studies on the fetal outcomes of pregnant patients 
admitted to ICU, the study also assessed whether the GRAMPT score 
obtained at the time of ICU admission might assist with triage. 
Methods
The study was conducted in the adult ICUs of a regional and 
tertiary hospital complex in Pietermaritzburg, SA. In the regional 
hospital, the ICU was a 6-bed mixed medical-surgical ICU, while 
the ICUs in the tertiary hospital consisted of a 5-bed mixed 
medical-surgical ICU and a 4-bed coronary care unit. Patients 
were admitted to these ICUs based on the clinical judgment of a 
consulting intensivist. Whether or not a patient was admitted was 
determined by their overall clinical condition, not their HIV sero-
status. ICUs in both hospitals were managed by the same team of 
medical health professionals. 
Data were obtained prospectively from the hospital charts of all 
antenatal and postpartum women admitted over a 10-month period 
(1 July 2010 - 30 April 2011). This duration was purely determined 
by convenience, due to time constraints. Each patient was classified 
as having a low (<50%) or high (≥50%) risk of death according to 
the GRAMPT stratification model. In each GRAMPT sub-category, 
patients were sub-divided according to their HIV status (obtained 
from hospital records) into HIV-positive, HIV-negative or HIV-
uknown. Each patient was followed up from the time of ICU 
admission until either the seventh day post-ICU discharge or until 
hospital discharge (whichever came first). Because many patients 
came from rural areas with poor telecommunication and transport 
services, it was not possible to follow patients up to the extent 
required to determine 28-day all-cause mortality. 
The primary maternal outcome considered was hypoxic-ischaemic 
brain injury (HIBI) or death, either in the ICUs or in the hospital 
wards in the week after ICU discharge. Patients who had cerebral 
death, i.e. permanent vegetative state, following cardiopulmonary 
resuscitation were regarded as having HIBI. The primary fetal 
outcomes considered were babies born alive, stillbirth, Apgar score 
at 5 minutes and birth weight. The secondary maternal outcomes 
considered were the duration of stay in ICU, mechanical ventilation of 
the patient, duration of ventilation, use of inotropes and blood/blood 
products, and whether the patient had a tracheostomy, laparotomy/
re-laparotomy, re-intubation or renal replacement therapy while 
in ICU, and the need for re-admission to ICU. The secondary fetal 
outcome considered was whether or not the delivery of the fetus was 
undertaken to facilitate maternal care. 
Most obstetric patients are admitted to ICUs in the puerperium. To 
increase the sample size for meaningful results of fetal outcomes, we 
evaluated patients who were delivered of their babies: (i) within 24 hours 
before ICU admission, (ii) during their stay in ICU and (iii) within 
24 hours after ICU discharge. This choice was based on the assumption 
that the outcome of delivery will be influenced predominantly at these 
periods by the same events that led to ICU admission.
Institutional ethical and hospital permission were obtained prior 
to study commencement. Informed consent was not obtained from 
individual patients. This was waived by the ethics committee because 
the study was observational and critically ill patients were adjudged 
to be too ill to give informed consent. Moreover, data were only 
obtained from the hospital charts and were kept confidential.
The GRAMPT model
This is a risk stratification or outcome prediction model devised 
for critically ill obstetric patients (gestational >20 weeks) and 
gynaecological patients (gestational age <20 weeks). The variables in 
the GRAMPT model are the Glasgow coma score (GCS), Respiratory 
rate (Resp), Age in years, Mean arterial pressure (MAP), pH, and 
Temperature (°C). The GRAMPT model has three different formulae 
based on the gestational age and pathology (thus adjusting for the effect 
of the intrinsic potential of each disease on mortality). The applicable 
formula is used to calculate the GRAMPT score for each patient. 
A calculated GRAMPT score above a threshold of 0.21 in 
hypertensive obstetric patients, 0.31 in non-hypertensive obstetric 
patients and 0.32 in gynaecological patients predicts >50% risk of 
maternal death.
The GRAMPT score, as initially devised by Paruk, was calculated 
using the patient’s age and the worst values of each parameter (GCS, 
Resp, MAP, pH and temperature) during the first 24 hours following 
ICU admission.[5] In contrast, in our study, we intentionally used the 
GRAMPT score obtained at the time of the patients’ admission to 
ICU. This was done in an effort to identify whether the GRAMPT 
score obtained at the time of ICU admission might assist with triage. 
Statistical analysis
Data were analysed using SPSS 19 and results are presented as 
frequencies, percentages, median, mean and range. Where possible, 
risk was determined by relative risk (RR) regardless of the sample size. 
The areas under the receiver operating characteristic (ROC) curves 
(AUC) were calculated to assess the performance of the GRAMPT 
model in predicting mortality/HIBI. Statistical significance was 
assumed at p<0.05. The sample size was not calculated before 
the study commenced because the study duration was based on 
convenience due to time constraints.
Results
Of the 919 patients admitted to the ICUs during the study period, 
82 (8.9%) were pregnant or post partum. Two pregnant patients who 
were admitted to the ICU in June 2010 were still in the ICU when data 
collection began in July 2010, and were included in the study, resulting 
in a sample size of 84. The proportion of patients admitted to the ICU 
was 51 (60.7%) in the regional hospitals and 33 (39.3%) in the tertiary 
hospitals. Overall, 66 (78.6%) postpartum patients and 18 (21.4%) 
antepartum patients constituted the study cohort.
The HIV sero-status was HIV-unknown in 11 (13.1%) patients, 
HIV-negative in 42 (50%) and HIV-positive in 31 (36.9%). The CD4 
count was known in 22 (71%) of the HIV-positive women. Only 25% 
of those with a CD4 count ≤200 cells/µl were receiving co-trimoxazole 
prophylaxis. Of those who were HIV-positive, 8 (25.8%) were 
receiving ART while 10 (32.3%) were receiving zidovudine (AZT). 
Among the 19 HIV-positive patients whose gestational ages were 
known to be >14 weeks, 12 (63.3%) were receiving either ART or 
AZT prophylaxis. 
The patients were aged 15 - 43 years (overall mean 25.1 years; SD 
±7.17). The mean age of the HIV-unknown patients was 24.09 years 
(SD ±6.20), HIV-negative patients 22.29 years (SD ±6.37) and HIV-
positive patients 29.19 years (SD ±7.17). Most (56.0%) were aged 20 
- 34 years and this age group comprised the majority in both HIV-
positive (64.5%) and HIV-negative (47.2%) patients. 
The pre-ICU admission diagnosis and the indications for ICU 
admission are shown in Table 1. The ROC curve in Fig. 1. shows 
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the performance of the GRAMPT model in predicting mortality or 
HIBI. The primary maternal outcome is shown in Table 2. Death 
and HIBI were commoner in HIV-positive patients than in HIV-
negative patients: 11 deaths and 1 HIBI (38.71%) v. 4 deaths and 2 
HIBI (14.29%) The following patients with a high GRAMPT score 
died or had HIBI: 7 (63.6%) HIV-positive patients and 2 (33.3%). 
HIV-negative patients. The relative risk (RR) of death/HIBI among 
HIV-positive patients with a high GRAMPT score was 1.91 (CI 95% 
0.57 - 6.44). The percentage who had a low GRAMPT score and 
survived were: 55 (83.3%) of the total patient population, 15 (75%) 
HIV-positive patients and 32 (88.9%) HIV-negative patients.
Eight patients underwent cardiopulmonary resuscitation before 
ICU admission. Following their admission to ICU, 2 (25%) survived, 
3 (37.5%) died and 3 (37.5%) had HIBI. The pre-ICU diagnoses of 
the 18 patients who died were pneumonia (3), eclampsia (3), placental 
abruption (2), isolated renal failure (2), valvular heart disease (1) and 
gunshot (1). Of the 22 (71%) HIV-positive women with a known CD4 
count, 2 (50%) of the 4 patients with a CD4 count of <200 cells/ µl died 
or had HIBI; but among the 18 women with a CD4 count >200 cells/µl, 
6 (33.33%) died or had HIBI.
All individual secondary maternal outcomes (Table 3) and fetal 
outcomes (Table 4) were worse among HIV-positive than HIV-negative 
patients but differences were not statistically significant. 
Discussion
Pregnant and postpartum patients constituted 8.9% of all admissions 
to the adult ICUs in our study. This figure is less than the 13.6% 
reported in a similar study done in Durban, SA,[9] which preceded the 
widespread use of effective ART. Nevertheless, our figure is within 
the range of 0.4 - 16% reported by Pollock et al., in their systematic 
review on pregnant and postpartum admissions to the ICUs.[10] The 
majority (78.6%) of our patients were in their postpartum period. 
Table 1. The main pre-ICU admission diagnosis and the main indication for ICU admission
Diagnosis/indication
HIV status, n (%)
HIV unknown (N=11) HIV-negative (N=42) HIV-positive (N=31) Total (N=84)
Pre-ICU admission diagnosis
Eclampsia 3 (27.27) 13 (30.95) 3 (9.68) 19 (22.62)
Severe pre-eclampsia 1 (9.09) 6 (14.29) 1 (3.23) 8 (9.52)
Pneumonia 0 (0) 0 (0) 6 (19.35) 6 (7.14)
Placental abruption 0 (0) 4 (9.52) 3 (9.68) 7 (8.33)
Puerperal sepsis 1 (9.09) 1 (2.38) 3 (9.68) 5 (5.95)
C/section for breech, FC & CPD 0 (0) 3 (7.14) 1(3.23) 4 (4.76)
Placenta praevia 0 (0) 3 (7.14) 1 (3.23) 4 (4.76)
Abortion 1 (9.09) 1 (2.38) 2 (6.45) 4 (4.76)
Valvular heart disease 0 (0) 2 (4.76) 1 (3.23) 3 (3.57)
Others 5 (45.45) 9 (21.43) 10 (32.26) 24 (28.57)
Indication for ICU admission
Obstetric haemorrhage 2 (18.18) 12 (28.57) 8 (25.81) 22 (26.19)
Sepsis 3 (27.27) 1 (2.38) 6 (19.35) 10 (11.90)
Respiratory failure 0 (0) 1 (2.38) 8 (25.81) 9 (10.71)
Repeated fits 1 (9.09) 4 (9.52) 2 (6.45) 7 (8.33)
Monitoring 1 (9.09) 1 (2.38) 4 (12.90) 6 (7.14)
Pulmonary oedema 0 (0) 4 (9.52) 1 (3.23) 5 (5.95)
Low Glasgow coma scale 2 (18.18) 2 (4.76) 0 (0) 4 (4.76)
Cardiac arrest 0 (0) 4 (9.52) 0 (0) 4 (4.76)
Others 2 (18.18) 13 (30.95) 13 (41.94) 17 (20.24)
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Fig. 1. ROC curve (for all patients) showing the performance of GRAMPT 
in predicting death or hypoxic ischaemic brain injury. *The area under 
the curve (AUC) for patients in each GRAMPT subcategory was 0.57 
(95% CI 0.23 - 0.91), 0.72 (CI 0.48 - 0.96) and 0.68 (CI 0.47 - 0.90) for 
gynaecological, hypertensive obstetric and non-hypertensive obstetric 
patients, respectively. 
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Recent studies report that high proportions (between 76.7%[11] and 
95.3%[12]) of postpartum patients are admitted to ICUs. In contrast, 
a tertiary centre in Saudi Arabia reports that 78.6% of patients were 
admitted to ICUs in the antenatal period.[13] These conflicting reports 
may be due to different indications for ICU admission in different 
centres. It is likely, however, that the initiating adverse events occur 
in the antenatal period. The 2008 - 2010, Saving Mothers’ Report 
indicates that a considerable number of women in SA die in the 
postpartum period, following an antenatal adverse event.[8] 
In our study, 36.7% of HIV-positive patients whose pregnancies 
were >14 weeks were not receiving ART, despite published SA national 
clinical guidelines recommending that all HIV-positive pregnant 
patients with a CD4 count >350 cells/µl should be initiated on AZT 
from 14 weeks’ gestation to prevent mother-to-child transmission, 
while those with a CD4 count <350 cells/µl should be initiated on 
ART irrespective of their gestational age. Our study also showed that 
only 25% of HIV-positive patients with a CD4 count <200 cells/µl 
were receiving co-trimoxazole. These factors may be contributing to 
the high incidence of pneumonia among HIV-positive patients.
The most common overall pre-ICU admission diagnosis among 
pregnant patients admitted to our ICUs was pre-eclampsia/eclampsia 
syndrome (32.1%). This is similar to the findings of other studies. [10,13] 
However, among HIV-positive patients, pneumonia was the commonest 
pre-ICU admission diagnosis, probably because HIV is associated with 
pulmonary infections due to immune supression. Pre-eclampsia/
eclampsia syndrome was commoner among our HIV-negative than 
HIV-positive patients. This may be because HIV-positive patients are 
less likely to mount a sufficient immunological response to develop 
pre-eclampsia/eclampsia, especially if they are not receiving ART.[14] 
A review of the literature[15] supports our findings that respiratory 
failure is the most common indication for admitting HIV-positive 
patients to ICUs. Major obstetric haemorrhage however, was the 
commonest indication for ICU admission among our HIV-negative 
patients; this possibly reflects the high prevalence of placental 
abruption and abdominal delivery. 
The ROC showed that the GRAMPT model as a predictor of death 
or HIBI performed best among hypertensive obstetric patients (ROC: 
AUC 0.72; 95% CI 0.48 - 0.96). This scoring system can be valuable as 
a predictor of mortality/survival at the time of admitting a pregnant 
or post partum patient to ICU. However, it should be noted that, for 
practical reasons, our usage of the GRAMPT score was based also 
on parameters available at the time of admission, and not solely on 
abnormal parameters measured over the first 24 hours, as in the 
original definition of GRAMPT by Paruk. It is possible that the use 
of the original method of GRAMPT scoring would have improved 
this model’s predictive value. Given GRAMPT’s performance in 
this study, we suggest that this model may be used to assist with 
patient triage (especially of hypertensive obstetric patients) for ICU 
admission by providing important additional information. The 
caveat, however, is that the inconsistency of mathematical models 
in predicting ICU survival among pregnant women admitted to 
different ICUs[4] demands that the performance of GRAMPT needs 
to be validated at individual centres prior to its use.
Of the 18 maternal deaths, 15 occurred in the ICUs while 3 
occurred in the ward within 7 days of ICU discharge (a ratio of 5:1). 
This is because some clinical conditions can worsen soon after ICU 
discharge. Maternal deaths among obstetric patients in ICUs is as low 
as zero in some centres in Australia, Canada and Saudi Arabia[10] and 
as high as 43.6% in India.[16] Although the profile of obstetric patients 
admitted to ICUs in well-resourced and under- resourced countries 
is similar,[10] the difference in percentage of maternal deaths may be 
related to differences in obstetric services. In our study, the increased 
rate of death among HIV-positive patients is probably related to 
infectious morbidity noted among this group of patients, since not all 
were on ART. In the USA, the use of any ART among HIV-positive 
patients admitted to ICU showed a tendency towards decreased 
mortality, but this did not reach statistical significance (OR 0.53; 95% 
CI 0.22 - 1.33).[17] 
The differences in the utilisation of ICU facilities observed in 
different centres are largely related to the patients’ profile that includes 
severity of illness and response to treatment. In this study for instance, 
the length of ICU stay varied from 10 hours to 37.0 days with a median 
of 2.0+36.6 days. However, a systematic review by Pollock et al.[10] 
reflected a mean ICU stay of 1.0 - 8.8 days.The use of mechanical 
Table 2. Primary maternal outcome (N=84)
HIV status GRAMPT score*
Outcome, n (%)
Survived HIBI Died† Total
Unknown Low 8 0 2 10
High 0 0 1 1
Total 8 0 3 11
Negative Low 32 1 3 36
High 4 1 1 6 (14.29)
Total 36 2 4 42
Positive Low 15 0 5 20
High 4 1 6 11 (35.42)
Total 19 1 11 31
Total Low 55 (87.30) 1 (33.33) 10 (55.56) 66 (78.57)
High 8 (12.70) 2 (66.67) 8 (44.44) 18 (21.43)
Total 63 3 18 84
HIBI = hypoxic-ischaemic brain injury.
*  The number of patients in each of the GRAMPT subcategories were 15 (17.9%) gynaecological, 31 (37.0%) hypertensive obstetric and 38 (45.3%) non-hypertensive obstetric patients. Each 
patient had only one of the following: survived, died or HIBI.†  The term ‘maternal death’ as used in this study refers to mothers who died during the study, and includes one death from gunshot, recognising that death from gunshot does not meet the ICD 
10 definition of maternal death.
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ventilation was very high (81.0%) among our patients compared with 
58% reported in a regional hospital in Hong Kong.[18] Nonetheless, our 
findings are comparable with the 85% reported in Turkey.[19] In this 
study the use of tracheostomy and dialysis was 4% and 5%, respectively, 
compared with 11.9% and 9.52% respectively in our study. 
Overall, the individual secondary maternal outcomes measures 
were worse among HIV-positive patients although this disparity 
did not reach statistical significance. These differences in these 
secondary maternal outcomes may reflect that 35.4% of HIV-positive 
and 14.3% of HIV-negative patients had high GRAMPT scores (a 
marker of disease severity). Not surprisingly, HIV-positive women 
had a longer duration of stay in ICU. Also, the severity of illness 
could account for a higher percentage of re-admission among HIV-
positive patients. The use of mechanical ventilation, duration of 
mechanical ventilation and re-intubation were more common among 
HIV-positive patients among whom respiratory failure was more 
prevalent. Their longer duration of ventilation may also account 
for the increased use of tracheostomy. The use of inotropic agents, 
and laparotomy/re-laparotomy were more common in HIV-positive 
patients as a result of sepsis in this group. The differences in the use of 
blood products and renal replacement therapy are difficult to explain. 
Apgar scores of 1 - 6 were more common in infants of HIV-
negative than HIV-positive patients. We think that this may be 
due to the increased use of sedation prior to delivery in obstetric 
hypertensive patients. Stillbirth and low birth weight while worse 
among HIV-positive than -negative patients, were not statistically 
different (p=0.09 and 0.14, respectively). Generally, each of the fetal 
outcomes is difficult to explain by any single reason. 
Table 3. Secondary maternal outcomes
Secondary outcome HIV-unknown HIV-negative HIV-positive Total
RR in HIV-positive 
patients (95% CI) p-value
Days of stay in ICU, median±SD* 36.60±2.08 1.83±25.98 2.04±20.69 2.0±36.60 
Patients, n 11 42 31 84
(range: 10 hours - 37.02 days)
Days of MV, median±SD 0.63±32.52 0.88±26.23 2.04±20.94 1.27±32.50
Patients, n n=9† n=33 n=25 n=67
(range: 30 minutes - 32.50 days)
Use of MV (%) 0.83
No 1 (9.09) 9 (21.43) 6 (19.35) 16 (19.05) 1.03 (0.81 - 1.30)
Yes 10 (90.91) 33 (78.57) 25 (80.65) 68 (80.95)
Use of inotropes, n (%) 0.17
No 7 (63.64) 27 (64.29) 15 (48.39) 49 (58.33) 1.45 (0.85 - 2.46)
Yes 4 (36.36) 15 (35.71) 16 (51.61) 35 (41.67)
Use of blood products, n (%) 0.54
No 3 (27.27) 22 (52.38) 14 (45.16) 39 (46.43) 1.15 (0.73 - 1.81)
Yes 8 (72.72) 20 (47.620) 17 (54.84) 45 (53.57)
Use of tracheostomy, n (%) 0.65
No 9 (81.82) 38 (90.48) 27 (87.10) 74 (88.10) 1.35 (0.37 - 5.00)
Yes 2 (18.18) 4 (9.52) 4 (12.90) 10 (11.90)
Use of laparotomy/re-laparotomy, n (%) 0.24
No 6 (54.55) 38 (90.48) 25 (80.65) 69 (82.14) 2.03 (0.63 - 6.59)
Yes 5 (45.45) 4 (9.52) 6 (19.35) 15 (17.86)
Use of re-intubation (except for medical 
procedure), n (%)
0.12
No 10 (90.91) 41 (97.62) 27 (87.10) 78 (92.86) 5.42 (0.64 - 46.14)
Yes 1 (9.09) 1 (2.38) 4 (12.90) 6 (7.14)
Re-admission to ICU, n (%) 0.83
No 10 (90.91) 41 (97.62) 30 (96.77) 81 (96.43) 1.36 (0.09 - 20.83)
Yes 1 (9.09) 1 (2.38) 1 (3.23) 3 (3.57)
Renal replacement therapy, n (%) 0.24
No 11 (100) 39 (92.86) 26 (83.87) 76 (90.48) 2.26 (0.58 - 8.75)
Yes 0 (0) 3 (7.14) 5 (16.13) 8 (9.52)
SD = standard deviation; RR = relative risk; MV = mechanical ventilation. 
*Duration of stay in ICU is the time interval between the patient’s arrival in the ICU for admission and her departure after discharge.
† Patient number 14 (with an unknown HIV status and low GRAMPT score) had MV but was excluded from the calculation of median days of MV because her duration of ventilation could not 
be established.
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There are limitations to this study. Most importantly, sample 
size calculation was not done prior to data collection. The wide 
confidence limits in the RR may be ascribed to the relatively small 
size of our study. Other limitations were: (i) the use of blood products 
and inotropes outside the ICU setting was not evaluated. Usage of 
these agents prior to ICU admission may reduce their usage in the 
ICUs; (ii) the HIV sero-status was unknown in 11 (13.1%) patients; 
(iii) due to sparse distribution of data within tables, not all the 
outcome measures were presented under low and high GRAMPT 
sub-categories or under specific diagnosis; (iv) the performance of 
GRAMPT as an outcome predictor could have been underestimated 
because the GRAMPT scores obtained at the time of patients’ 
admission to the ICUs were used, rather than the worst scores in 
the first 24 hours following ICU admission; (v) due to the fact that 
many patients came from rural areas with poor telecommunication 
and transport services, it was not possible to achieve follow-up to the 
extent required to determine 28-day all-cause mortality. Despite these 
shortcomings, to our knowledge, our study is the first to risk stratify 
pregnant patients utilising the GRAMPT score obtained at the time 
of patients’ admission to ICU. 
Conclusion
All maternal and fetal outcomes, except for infant Apgar scores of 
1 - 6, showed a worse trend among HIV-positive than HIV-negative 
patients. These findings may hinder admission of HIV-positive 
pregnant patients to ICUs in favour of HIV-negative patients, who 
may be adjudged to have better outcomes. Larger studies are therefore 
urgently needed to investigate these trends more completely. Until 
such studies are done, we believe that HIV sero-status should not be 
used as an isolated determinant of admission to ICUs.
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Table 4. Fetal outcomes













RR in HIV-positive 
patients (95% CI) p-value
APGAR score in 5 minutes
Stillborn 1 (33.33) 10 (34.48) 8 (61.54) 19 (42.22) 1.78 (0.79 - 3.45) 0.09
1 - 6 1 (33.33) 6 (20.69) 1 (7.69) 8 (17.78) 0.37 (0.05 - 2.78) 0.33
7 - 10 1 (33.33) 13 (44.83) 4 (30.77) 18 (40.00)
Birth weight (g)
>500 - <2 500 2 (66.67) 16 (55.17) 10 (76.92) 28 (62.22) 1.39 (0.90 - 2.17) 0.14
>2 500 - 4 000 1 (33.33) 13 (44.83) 3 (23.08) 17 (37.78)
Emergency abdominal delivery to facilitate maternal care
No 3 (100) 28 (96.55) 11 (84.62) 42 (93.33) 4.46 (0.44 - 44.93) 0.20
Yes 0 (0) 1 (3.45) 2 (15.38) 3 (6.67)
*  These data were for patients who were delivered of their babies: (i) within 24 hours before ICU admission (42; 93.3%); (ii) while on admission in ICU (3; 6.7%); and (iii) within 24 hours after 
ICU discharge (0; 0%). 
